<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30319215</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0971-3026</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>28</Volume>                    <Issue>3</Issue>                    <PubDate>                        <MedlineDate>2018 Jul-Sep</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>The Indian journal of radiology &amp; imaging</Title>                <ISOAbbreviation>Indian J Radiol Imaging</ISOAbbreviation>            </Journal>            <ArticleTitle>Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings.</ArticleTitle>            <Pagination>                <MedlinePgn>354-361</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4103/ijri.IJRI_78_18</ELocationID>            <Abstract>                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">To determine the correlation between mammography and ultrasound features of breast cancer with molecular subtypes and to calculate the predictive value of these features.</AbstractText>                <AbstractText Label="Materials and Method" NlmCategory="UNASSIGNED">This is a prospective study of consecutive patients with breast cancer presenting between January 2016 and July 2017, who underwent mammography and/or ultrasound of breast and excision of the breast mass. Patients with contralateral breast mass, metastases, h/o prior cancer treatment, and other malignancies were excluded. On mammography, the presence or absence of microcalcification was noted. On ultrasound examination size, margins, microcalcification, posterior acoustic features, vascularity, and axillary nodes were assessed. Margins were categorized into circumscribed and non-circumscribed. Posterior acoustic features were classified into four categories: shadowing, enhancement, mixed, and no changes. Vascularity was assessed based on Adler's index into grades 0, 1, 2, and 3. Grades 0 and 1 were considered low and 2 and 3 were high.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Tumors with non-circumscribed margins and posterior acoustic shadowing were likely to be luminal A or B subtype of breast cancer [odds ratio (OR) 5.78; 95% confidence interval (CI) 3.68-9.80; <i>P</i> &lt; 0.0001]. Tumors with non-circumscribed margins, posterior acoustic shadowing, and high vascularity were more likely to be luminal B subtype (OR 2.88; 95% CI 2-4.14; P- &lt;0.0001). Tumors with microcalcification and posterior mixed acoustic pattern were strongly associated to be HER2-positive (OR 5.48; 95% CI 3.06-9.80; <i>P</i> &lt; 0.0001). Tumors with circumscribed margins and posterior acoustic enhancement were highly suggestive of triple-negative breast cancer (OR 7.06; 95% CI 4.64-10.73; <i>P</i> &lt; 0.0001).</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Microcalcification detected on mammography and certain ultrasound features such as circumscribed or non-circumscribed margins, posterior acoustic features, and vascularity are strongly correlated in predicting the molecular subtypes of breast cancer, and thus may further expand the role of conventional breast imaging.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rashmi</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiodiagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kamala</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiodiagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murthy</LastName>                    <ForeName>S Sudha</ForeName>                    <Initials>SS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology and Lab Diagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kotha</LastName>                    <ForeName>Swapna</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiodiagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rao</LastName>                    <ForeName>Y Suhas</ForeName>                    <Initials>YS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiodiagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chaudhary</LastName>                    <ForeName>K Veeraiah</ForeName>                    <Initials>KV</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiodiagnosis, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>India</Country>            <MedlineTA>Indian J Radiol Imaging</MedlineTA>            <NlmUniqueID>8503873</NlmUniqueID>            <ISSNLinking>0970-2016</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource>                <PMID Version="1">25220842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2010 May;36(3):206-15</RefSource>                <PMID Version="1">20060649</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Radiat Oncol. 2009 Oct;19(4):204-10</RefSource>                <PMID Version="1">19732684</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acad Radiol. 2006 Oct;13(10):1211-8</RefSource>                <PMID Version="1">16979070</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AJR Am J Roentgenol. 2012 Sep;199(3):W402-8</RefSource>                <PMID Version="1">22915433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diagn Interv Radiol. 2015 Nov-Dec;21(6):448-53</RefSource>                <PMID Version="1">26359880</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2011 Jul;18(3):146-51</RefSource>                <PMID Version="1">20972742</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2014 Feb;40(1):129-38</RefSource>                <PMID Version="1">23891266</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2008 Feb;246(2):367-75</RefSource>                <PMID Version="1">18180338</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Feb 21;8(8):13855-13862</RefSource>                <PMID Version="1">28099938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Jun 05;5:11085</RefSource>                <PMID Version="1">26046791</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Res Notes. 2012 Jul 25;5:376</RefSource>                <PMID Version="1">22830453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2009 May 20;101(10):736-50</RefSource>                <PMID Version="1">19436038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2017 Jan 1;123(1):114-121</RefSource>                <PMID Version="1">27571243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AJR Am J Roentgenol. 2013 Feb;200(2):284-90</RefSource>                <PMID Version="1">23345347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathol Res Pract. 2005;201(11):713-25</RefSource>                <PMID Version="1">16325514</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">mammography</Keyword>            <Keyword MajorTopicYN="N">microcalcifications</Keyword>            <Keyword MajorTopicYN="N">molecular subtype</Keyword>            <Keyword MajorTopicYN="N">posterior acoustic features</Keyword>            <Keyword MajorTopicYN="N">predicting value</Keyword>            <Keyword MajorTopicYN="N">ultrasound</Keyword>            <Keyword MajorTopicYN="N">vascularity</Keyword>        </KeywordList>        <CoiStatement>There are no conflicts of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30319215</ArticleId>            <ArticleId IdType="doi">10.4103/ijri.IJRI_78_18</ArticleId>            <ArticleId IdType="pii">IJRI-28-354</ArticleId>            <ArticleId IdType="pmc">PMC6176670</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>